ORIC Pharmaceuticals annual meeting elects directors, ratifies KPMG as auditor

Oric Pharmaceuticals, Inc.

81.9% of outstanding shares represented at June 14, 2023 annual meeting.
Jacob M. Chacko, M.D. elected with 31,394,488 votes for, 576,707 withheld.
Mardi C. Dier elected with 25,659,351 votes for, 6,311,844 withheld.
KPMG LLP ratified as independent auditor for FY2023: 36,376,853 for, 1,701 against, 553,159 abstain.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Oric Pharmaceuticals, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm at the 2023-06-14 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-14

Exact text from the filing

The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified based on the following results of voting:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Oric Pharmaceuticals, Inc. shareholders approved Election of Class III directors at the 2023-06-14 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-14

Exact text from the filing

Each of the following nominees was elected to serve as a Class III director, to hold office until the Company’s 2026 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier resignation or removal:

View on SEC.gov

Browse all shareholder votes →

Oric Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-167893

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.